InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Jaxxm PremiumMember
11/14/23 11:13 AM
profile icon
RDOG Free
04/02/16 11:10 PM
profile icon
holycow Free
03/12/16 9:10 PM
profile icon
truthhurts Free
02/09/16 2:38 AM
profile icon
truthhurts Free
02/09/16 2:23 AM
profile icon
nw_La Free
02/02/16 4:07 PM
profile icon
Paulness Free
09/16/15 7:36 AM
profile icon
Paulness Free
08/24/15 10:20 PM
profile icon
truthhurts Free
07/02/15 6:11 AM
profile icon
truthhurts Free
06/25/15 2:50 AM
profile icon
truthhurts Free
06/23/15 5:59 AM
profile icon
nw_La Free
06/10/15 4:15 PM
profile icon
Roscoe85 Free
05/19/15 11:26 AM
profile icon
Paulness Free
05/18/15 9:24 PM
profile icon
Hardthought Free
05/18/15 2:32 PM
profile icon
Hardthought Free
05/18/15 2:27 PM
profile icon
truthhurts Free
01/01/15 6:45 AM
profile icon
truthhurts Free
10/03/14 5:23 AM
profile icon
Paulness Free
09/23/14 9:19 PM
profile icon
gzone Free
09/03/14 10:27 AM
profile icon
truthhurts Free
09/03/14 3:25 AM
profile icon
gzone Free
08/15/14 12:48 PM
profile icon
truthhurts Free
08/15/14 11:50 AM
profile icon
Paulness Free
08/14/14 11:06 PM
profile icon
gdepc Free
08/14/14 7:00 PM
profile icon
gzone Free
08/14/14 11:12 AM
profile icon
truthhurts Free
08/13/14 4:28 PM
profile icon
gzone Free
08/10/14 10:48 PM
profile icon
Paulness Free
08/10/14 7:53 PM
profile icon
gzone Free
08/10/14 2:56 PM
profile icon
truthhurts Free
08/06/14 1:02 AM
profile icon
Paulness Free
07/31/14 12:58 PM
profile icon
wanaB Free
07/29/14 4:49 PM
profile icon
Paulness Free
07/23/14 6:46 PM
profile icon
Paulness Free
07/23/14 5:04 PM
profile icon
nw_La Free
07/21/14 1:11 PM
profile icon
Ubertino Free
07/18/14 4:56 PM
profile icon
scion Grandfathered
07/18/14 4:28 PM
profile icon
scion Grandfathered
07/18/14 3:44 PM
profile icon
Paulness Free
07/07/14 12:20 AM
profile icon
Paulness Free
04/18/14 7:09 PM
profile icon
holycow Free
04/17/14 7:34 PM

Cytogenix (fka CYGX) RSS Feed

Followers
154
Posters
506
Posts (Today)
0
Posts (Total)
64738
Created
07/14/03
Type
Free
Moderators

CytoGenix, Inc.
Phone: (830) 632-5944
Fax: (830) 632-5944

CytoGenix is a Nevada public corporation traded under the symbol CYGX.PK.

http://www.pr-inside.com/cytogenix-inc-to-become-sec-compliant-r2160873.htm

Email: info@cytogenix.com

Transfer Agent

Our Transfer Agent is Nevada Agency and Trust Company. Shareholders of record with questions about lost certificates, notification of change of address, or other matters should contact:

Nevada Agency and Trust Company
50 West Liberty, Suite 880
Reno, Nevada, 89501
(775) 322-0626 Telephone
(775) 332-5623 Fax
www.natco.org


 Expansion is in our forecast...



CYTOGENIX MISSION STATEMENT
"Our mission is to create human benefit and monetary value by developing biopharmaceutical agents that regulate genes to cure the root cause of disease rather than ameliorate symptoms.We will adhere to the highest ethical and scientific standards of conduct in our dealings with investors, employees, outside scientists and clinicians, the public and government regulatory agencies." "CytoGenix, Inc., with headquarters in Houston, Texas, is dedicated to developing biopharmaceutical compounds and services based on its proprietary gene regulating technology. We control U.S. and foreign patents for a technology that is effective in targeting and reducing gene expression. We have applied this technology to the development of topical compounds for the treatment of skin diseases and disorders such as, Herpes, Alopecia, Psoriasis, and contact dermatitis." Recently, CytoGenix Inc. Invents Revolutionary Large-Scale Manufacturing Process for High-Purity DNA."

http://cytogenix.com/index.html

Management
   
 
 
 
 
John J. Rossi, PhD 
Kevin Cassidy
 
Frédéric Kendirgi, PhD
 
Cory Huang, MS, MA, MBA
 
Jett
 
Cy A. Stein, MD PhD

Peter Glazer, MD, PhD
 
Steven Udem, MD

Sergio Rosini, PhD
 
Campbell Murray, MD

http://ih.advfn.com/p.php?pid=nmona&article=44863243&symbol=CYGX

Biotech Research and Others


J.M. Dutton & Assoc.- http://www.jmdutton.com/Research/CYGX/Index.html

Clinical Trials Info - http://www.centerwatch.com/
GenomeWeb - http://www.genomeweb.com/
News - http://www.biospace.com/
http://www.loonycat.com/Genomics.htm
Drug Approval Site http://www.fda.gov/cder/approval/index.htm
Linfield College Chemistry Dept. http://www.linfield.edu/chem/chemlinks.html#National
Biodefense Website - http://www.healthtech.com/2002/btr/
Center for Disease Control http://www.cdc.gov/
http://www.investorshub.com/boards/read_msg.asp?message_id=81022


Technical Analysis Link

http://www.stockta.com/cgi-bin/analysis.pl?symb=CYGX&num1=7&cobrand=

http://www.americanbulls.net/StockPage.asp?CompanyTicker=CYGX&MarketTicker=OTC&TYP=S

http://charts3.barchart.com/chart.asp?sym=CYGX&data=A&jav=adv&vol=Y&evnt=adv&gri....

http://www.tradingday.com/

http://www.best-charts.com/

A site to learn how to chart
http://www.stockcharts.com/education/ 
 

CytoGenix, Inc. is a Houston-based biopharmaceutical company pioneering the new field of gene based medicine and is focused on developing innovative vaccines and therapeutic products using its three proprietary technology platforms: synDNATM non-bacterial production methodology, single stranded DNA (ssDNA) expression, and oligonucleotide based anti-bacterial technologies. CytoGenix currently holds 13 granted patents and 57 international or US pending patent applications claiming methods and materials in connection with these platform technologies.

SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the Company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com. 

Board Info
Posts Today
0
Posts (Total)
64738
Posters
506
Moderators
New Post